perfosfamide has been researched along with African Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haake, R; Kersey, JH; Ramsay, NK; Uckun, FM; Weisdorf, D | 1 |
| Douay, L | 1 |
| Bast, RC; Bregni, M; De Fabritiis, P; Greenberger, J; Korbling, M; Lipton, J; Nadler, L; Ritz, J; Rothstein, L | 1 |
3 other study(ies) available for perfosfamide and African Lymphoma
| Article | Year |
|---|---|
Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone ma
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Antigens, Neoplasm; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Burkitt Lymphoma; CD24 Antigen; Complement System Proteins; Cyclophosphamide; Cytarabine; Flow Cytometry; Fluorescent Antibody Technique; Humans; Membrane Glycoproteins; Neoplasm Recurrence, Local; Neprilysin; Rabbits; Remission Induction; Tetraspanin 29; Transplantation, Autologous; Tumor Stem Cell Assay; Whole-Body Irradiation | 1992 |
Cyclophosphamide derivatives for in vitro cleansing of leukemic bone marrow.
Topics: Animals; Bone Marrow; Bone Marrow Transplantation; Burkitt Lymphoma; Cell Line; Cell Separation; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Experimental; Mice; Rats | 1985 |
Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement.
Topics: Antibodies, Monoclonal; Bone Marrow; Burkitt Lymphoma; Clone Cells; Complement System Proteins; Culture Techniques; Cyclophosphamide; Hematopoietic Stem Cells; Humans | 1985 |